IL155141A0 - Induction of blood vessel formation by polynucleotides encoding sphingosine kinases - Google Patents
Induction of blood vessel formation by polynucleotides encoding sphingosine kinasesInfo
- Publication number
- IL155141A0 IL155141A0 IL15514101A IL15514101A IL155141A0 IL 155141 A0 IL155141 A0 IL 155141A0 IL 15514101 A IL15514101 A IL 15514101A IL 15514101 A IL15514101 A IL 15514101A IL 155141 A0 IL155141 A0 IL 155141A0
- Authority
- IL
- Israel
- Prior art keywords
- induction
- blood vessel
- polynucleotides encoding
- vessel formation
- sphingosine kinases
- Prior art date
Links
- 230000006698 induction Effects 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 108010035597 sphingosine kinase Proteins 0.000 title 1
- 230000007998 vessel formation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23823000P | 2000-10-05 | 2000-10-05 | |
| PCT/EP2001/011513 WO2002028406A2 (en) | 2000-10-05 | 2001-10-05 | Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155141A0 true IL155141A0 (en) | 2003-10-31 |
Family
ID=22897001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15514101A IL155141A0 (en) | 2000-10-05 | 2001-10-05 | Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6610534B2 (de) |
| EP (1) | EP1401468A2 (de) |
| JP (1) | JP2004510741A (de) |
| AU (1) | AU2002224771A1 (de) |
| CA (1) | CA2424693A1 (de) |
| IL (1) | IL155141A0 (de) |
| NZ (1) | NZ525059A (de) |
| WO (1) | WO2002028406A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100798375B1 (ko) * | 1999-05-13 | 2008-01-28 | 존슨 앤드 존슨 파머슈티컬 리서치 앤드 디벨로프먼트 엘엘씨 | 스핀고신 키나제 효소 |
| KR20040048231A (ko) * | 2002-12-02 | 2004-06-07 | 주식회사 두산 | 신생혈관생성 억제제 및 그를 포함한 암 치료용 키트 |
| AU2003292636A1 (en) * | 2002-12-27 | 2004-07-29 | The New Industry Research Organization | Cell growth inhibitor using sphingosine kinase 2, method of constructing fused protein having its nuclear localization signal, method of screening drug candidate, and screening kit |
| FR2889200B1 (fr) * | 2005-07-27 | 2008-01-04 | Inst Vaisseaux Et Du Sang Ass | Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique |
| US8790678B2 (en) * | 2006-03-03 | 2014-07-29 | Washington University | Biomaterials having nanoscale layers and coatings |
| EP3813871A4 (de) | 2018-06-29 | 2022-10-12 | Icahn School of Medicine at Mount Sinai | Für anc80 codierende sphingolipid-metabolisierende proteine |
| CN109355269B (zh) * | 2018-10-21 | 2020-03-24 | 北京双因生物科技有限公司 | 鞘氨醇激酶1及其融合蛋白及其用途 |
| GB202410992D0 (en) * | 2024-07-26 | 2024-09-11 | Icosphere Biosciences Ltd | Process for making gutless helper-dependent adenoviruses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932540A (en) * | 1994-03-08 | 1999-08-03 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
| US6326007B1 (en) * | 1995-07-20 | 2001-12-04 | The Regents Of The University Of California | Attenuated lentivirus vectors expressing interferon |
| AUPO900297A0 (en) * | 1997-09-08 | 1997-10-02 | Medvet Science Pty. Ltd. | A method of modulating cellular activity |
| CA2329124A1 (en) | 1998-05-26 | 1999-12-02 | Office Of The Dean Of Research And Graduate Education | Sphingosine kinase, cloning, expression and methods of use |
| KR100798375B1 (ko) | 1999-05-13 | 2008-01-28 | 존슨 앤드 존슨 파머슈티컬 리서치 앤드 디벨로프먼트 엘엘씨 | 스핀고신 키나제 효소 |
| JP2003512072A (ja) * | 1999-10-28 | 2003-04-02 | ワーナー−ランバート・カンパニー | ヒトスフィンゴシンキナーゼ遺伝子 |
| AU3828301A (en) * | 2000-02-14 | 2001-08-27 | Curagen Corp | Novel sphingosine kinases |
-
2001
- 2001-10-04 US US09/970,516 patent/US6610534B2/en not_active Expired - Fee Related
- 2001-10-05 AU AU2002224771A patent/AU2002224771A1/en not_active Abandoned
- 2001-10-05 WO PCT/EP2001/011513 patent/WO2002028406A2/en not_active Ceased
- 2001-10-05 IL IL15514101A patent/IL155141A0/xx unknown
- 2001-10-05 EP EP01986264A patent/EP1401468A2/de not_active Withdrawn
- 2001-10-05 JP JP2002532230A patent/JP2004510741A/ja active Pending
- 2001-10-05 CA CA002424693A patent/CA2424693A1/en not_active Abandoned
- 2001-10-05 NZ NZ52505901A patent/NZ525059A/xx unknown
-
2003
- 2003-07-14 US US10/619,344 patent/US20040086487A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040086487A1 (en) | 2004-05-06 |
| CA2424693A1 (en) | 2002-04-11 |
| NZ525059A (en) | 2004-12-24 |
| WO2002028406A2 (en) | 2002-04-11 |
| US6610534B2 (en) | 2003-08-26 |
| AU2002224771A1 (en) | 2002-04-15 |
| EP1401468A2 (de) | 2004-03-31 |
| US20020099029A1 (en) | 2002-07-25 |
| WO2002028406A3 (en) | 2002-06-20 |
| JP2004510741A (ja) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1363702A4 (de) | Verfahren zur hemmung von kinasen | |
| EP1407001A4 (de) | Einweggefäss | |
| GB2393202B (en) | Methods of well treatment | |
| GB2384769B (en) | Infusion vessel | |
| AU5464601A (en) | Treatment of scale | |
| IL155141A0 (en) | Induction of blood vessel formation by polynucleotides encoding sphingosine kinases | |
| AU3828301A (en) | Novel sphingosine kinases | |
| IL161126A0 (en) | Single strength juice deacidification of ion-exchange column | |
| GB0108274D0 (en) | preparation of silicone resins | |
| GB0227114D0 (en) | Preparation of triethyl phostate | |
| TW453172U (en) | Structure of teakettle for making tea | |
| TW474151U (en) | Improved structure of tea making pot | |
| TW461552U (en) | Improvement of seven-string ancient lute | |
| TW475407U (en) | Improved structure of pressure pot | |
| TW456230U (en) | Improved structure of pot for frying yam balls | |
| TW489657U (en) | Improved structure of multifunctional water-therapeutic steam bathtub | |
| TW418613U (en) | Structure of 3-D breast pad | |
| TW573507U (en) | Improved structure of teapot | |
| TW499937U (en) | Improved structure of coffee kettle | |
| GB0105222D0 (en) | Diagnosis of dyslexia | |
| TW520773U (en) | Improved structure of expansion-slot bottom-plate | |
| TW472836U (en) | Tap structure capable of providing diversified art tap shape for use | |
| GB0105475D0 (en) | Bath water pillow | |
| TW439461U (en) | Improved structure of tea pot set | |
| TW456178U (en) | Improved structure of machine for making boiled dumplings |